Global Enzyme Linked Immunosorbent Assay (ELISA) Market, by Method (Direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA), by Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring & Pharmaceutical Industry & Transplantation), by Technology (Chemiluminescent, Colorimetric, & Fluorescent), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 2,016.1 Million in 2022 and is expected to exhibit a CAGR of 5.1% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Increasing product approvals by regulatory authorities and government organizations is expected to drive market growth over the forecast period. For instance, On June, 22, 2022, Pictor, an in vitro diagnostics company received The Conformitè Europëenne (CE) marking for its PictArray SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) antibody test to enable personalized Covid-19 assessment. The PictArray SARS-CoV-2 IgG ELISA kit has been designed to separately identify antibodies from Covid-19 infection and vaccination.
Global Enzyme Linked Immunosorbent Assay (ELISA) Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.
However, the COVID-19 pandemic had a positive impact on the global Enzyme Linked Immunosorbent Assay (ELISA) market, owing to increased research and development for ELISA kit for detection of Covid-19 infection. For instance, On May 14, 2020, Indian Council of Medical Research (ICMR) & National Institute of Virology (NIV), Pune, India developed and validated the indigenous IgG ELISA test ‘COVID KAVACH ELISA’ for antibody detection for COVID-19.The scientists at ICMR-NIV, Pune, India have developed and validated the completely indigenous IgG ELISA test for antibody detection for SARS-CoV-2.
Global Enzyme Linked Immunosorbent Assay (ELISA) Market: Key Developments
On October 26, 2021, Transasia Bio-Medicals, a manufacturing company of In-vitro Diagnostic products had announced the launch of high sensitivity testing kit for hepatitis C virus. The ErbaLisa HCV Gen 4 Ag+Ab kit, is only indigenously developed 4th gen ELISA kit and has been evaluated by the National Institute of Biologicals (NIB), India.
Browse 34 Market Data Tables and 38 Figures spread through 156 Pages and in-depth TOC on “Global Enzyme Linked Immunosorbent Assay (ELISA) Market”- Forecast to 2030, Global Enzyme Linked Immunosorbent Assay (ELISA) Market, by Method (Direct ELISA, Indirect ELISA, Sandwich ELISA and Competitive ELISA), by Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring & Pharmaceutical Industry & Transplantation), By Technology (Chemiluminescent, Colorimetric, & Fluorescent), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in Enzyme Linked Immunosorbent Assay (ELISA) Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/enzyme-linked-immunosorbent-assay-market-1505
Moreover, increasing product launches by market players are expected to drive market growth during the forecast period. For instance, On September 3, 2020, Leinco Technologies, a biotechnology company and ADMA Biologics, Inc. a biopharmaceutical company had announced the launch of COVID-19 ImmunoRank Neutralization MICRO-ELISA, a proprietary, fully-validated ELISA assay for the detection of SARS-CoV-2 neutralizing antibodies in plasma. ImmunoRank is intended for use as an aid to identify individuals who produce an adaptive immune response to SARS-CoV-2.
Key Takeaways of the Global Enzyme Linked Immunosorbent Assay (ELISA) Market:
- Global Enzyme Linked Immunosorbent Assay (ELISA) market is expected to exhibit a CAGR of 5.1% during the forecast period due to increasing research and development by research institutes for developing ELISA kit. For instance, on December 21, 2021, researchers from the Primate Animal Study Center (PASC) of the Institute for Research and Community Service (IoRCS) IPB University, Indonesia succeeded in developing an ELISA (Enzyme-Linked Immunosorbent Assay)-based COVID-19 antibody kit. The antibody kit was known as ‘IPB ELISA Kit, COVID-19 Antibody’.
- Among Technology, the Chemiluminescent, segment holds a dominant position, owing to increasing presence of market players in the global Enzyme Linked Immunosorbent Assay (ELISA) market. For instance, Creative Diagnostics, a manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents provides CDSimple Chemiluminescent ELISA Kits indicated for detection of allergy, anemia, autoimmune diseases and infectious diseases.
- Among regions, North America is expected to hold the dominant position in market, owing to product launches by market players in the region. For instance, In October, 2020, VEO Diagnostics, a manufacturing company of medical diagnostic products had announced the launch and sole distribution rights in the U. S. to the ACCEL ELISA COVID-19 kit, a serological microplate-based enzyme linked Immunosorbent assay (ELISA) for the qualitative detection of total antibodies (including IgG, IgM, and IgA) to SARS-CoV-2 in human serum. ACCEL ELISA is intended for use as an aid in identifying individuals with an adaptive immune response to SARS CoV-2.
- Major players operating in the global Enzyme Linked Immunosorbent Assay (ELISA) market include Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., R&D Systems, Creative Diagnostics, Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.
